Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Senhwa's Pindnarulex in Combination Study with Pfizer's Talazoparib for the Treatment of Prostate Cancer Granted Approval to Initiate from Australian HREC 2022-06-06 21:00
Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS 2019-12-13 04:00
PBTC and Senhwa sign cooperation agreement to develop CX-4945 for pediatric brain tumor treatment 2018-06-12 21:00
1